Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Tony Hebden, PhD

Advertisement

Articles by Tony Hebden, PhD

Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy

ByStephen S. Johnston, MA,Timothy Juday, PhD,Amanda M. Farr, MPH,Bong-Chul Chu, PhD,Tony Hebden, PhD
June 19th 2014

Initiation of guideline-preferred first-line antiretroviral therapy (ART) was associated with better ART adherence and persistence and similar total healthcare expenditures among Medicaid-insured HIV patients.

Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

ByTeresa B. Gibson, PhD,Yonghua Jing, PhD,Jill E. Bagalman, MSW,Zhun Cao, PhD,John A. Bates, PhD,Tony Hebden, PhD,Robert A. Forbes, PhD,Jalpa A. Doshi, PhD
January 16th 2012

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.

Advertisement

Latest Updated Articles

  • Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
    Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

    January 16th 2012

  • Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy
    Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy

    June 19th 2014



Advertisement
Advertisement

Trending on AJMC

1

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

2

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

3

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

4

ICER Draft Flags High Cost of New Hypertension Drug Class

5

MDS/MPN Response Criteria Tied to Survival

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text